Brief: Ikena Oncology Presents Data At Aacr-Nci-Eortc Virtual Conference Demonstrating Potential Of Tead Inhibitors In Cancer Treatment
07/10/2021 14:15
Oct 7 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY PRESENTS DATA AT AACR-NCI-EORTC VIRTUAL
CONFERENCE DEMONSTRATING POTENTIAL OF TEAD INHIBITORS IN CANCER
TREATMENT
* IKENA ONCOLOGY - DATA INDICATES PROMISING INDICATIONS FOR
CLINICAL DEVELOPMENT OF IKENA'S NOVEL TEAD INHIBITOR, IK-930
Source text for Eikon: ID:nGNXbSMjS9
Further company coverage: IKNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals